Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -16.586% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) Cc1nn(Cc2c(F)cccc2Cl)c(C)c1[N+](=O)[O-]
b) COc1ccc(NC(=O)c2cc(-c3ccccn3)nc3ccccc23)cc1S(=O)(=O)N(C)C
Answer: b. COc1ccc(NC(=O)c2cc(-c3ccccn3)nc3ccccc23)cc1S(=O)(=O)N(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(NC(=O)c2cc(-c3ccccn3)nc3ccccc23)cc1S(=O)(=O)N(C)C
COc1ccc(NC(=O)c2cc(-c3ccccn3)nc3ccccc23)cc1S(=O)(=O)N(C)C
N-[3-(dimethylsulfamoyl)-4-methoxyphenyl]-2-pyridin-2-ylquinoline-4-carboxamide